Novo Integrated Sciences, Inc.
NVOS · OTC
8/31/2024 | 5/31/2024 | 2/29/2024 | 11/30/2023 | |
|---|---|---|---|---|
| Market Cap | $5,996 | $19,620 | $11,131 | $20,072 |
| - Cash | $845 | $1,540 | $652 | $1,640 |
| + Debt | $4,710 | $4,502 | $5,342 | $4,641 |
| Enterprise Value | $9,862 | $22,582 | $15,821 | $23,073 |
| Revenue | $3,081 | $3,152 | $3,171 | $3,891 |
| % Growth | -2.3% | -0.6% | -18.5% | – |
| Gross Profit | $1,578 | $897 | $1,324 | $1,944 |
| % Margin | 51.2% | 28.5% | 41.8% | 50% |
| EBITDA | $7,250 | -$10,096 | -$924 | -$2,869 |
| % Margin | 235.3% | -320.3% | -29.1% | -73.7% |
| Net Income | $5,002 | -$13,742 | -$2,746 | -$4,680 |
| % Margin | 162.4% | -436% | -86.6% | -120.3% |
| EPS Diluted | 0.26 | -0.74 | -0.16 | -0.28 |
| % Growth | 135.1% | -362.5% | 42.9% | – |
| Operating Cash Flow | -$546 | -$658 | -$1,714 | -$2,152 |
| Capital Expenditures | -$3 | -$2 | -$0 | $0 |
| Free Cash Flow | -$549 | -$660 | -$1,714 | -$2,152 |